Athersys Company
Clinical-stage biotech founded in 1995 and based in Cleveland, Ohio, developing MultiStem®, an allogeneic stem-cell therapy platform. Focused on conditions such as neurological injury, acute respiratory distress syndrome, and immune-mediated inflammation. MultiStem is designed as a scalable, off-the-shelf therapy with immunomodulatory and tissue-repair functions. (athersys.com)
%20.jpg)
Headquarters:
3201 Carnegie Avenue, Cleveland, OH.
Number Of Exists:
N/A
Estimated Revenue:
~$0.08M (latest); FY2022 $5.3M
Founded Date:
1995